The policy was released prior to VRBPAC or ACIP meeting, and no input from either. This has an obvious impact on annual formulation, but FDA staff were unable t

The policy was released prior to VRBPAC or ACIP meeting, and no input from either. This has an obvious impact on annual formulation, but FDA staff were unable to answer questions from the panel on it ( https://apnews.com/article/fda-vaccines-covid-boosters-kennedy-244bdc80f825f953782d35f68798d885 https://apnews.com/article/fda-vaccines-covid-boosters-kenne... ).